- Home
- CLSD vs DMA Comparison
CLSD vs DMA Comparison
Compare CLSD & DMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLSD
- DMA
- Stock Information
- Founded
- CLSD 2011
- DMA 2011
- Country
- CLSD United States
- DMA United States
- Employees
- CLSD N/A
- DMA N/A
- Industry
- CLSD Biotechnology: Pharmaceutical Preparations
- DMA Trusts Except Educational Religious and Charitable
- Sector
- CLSD Health Care
- DMA Finance
- Exchange
- CLSD Nasdaq
- DMA Nasdaq
- Market Cap
- CLSD 76.6M
- DMA 80.4M
- IPO Year
- CLSD 2016
- DMA N/A
- Fundamental
- Price
- CLSD $1.01
- DMA $8.81
- Analyst Decision
- CLSD Strong Buy
- DMA
- Analyst Count
- CLSD 6
- DMA 0
- Target Price
- CLSD $5.33
- DMA N/A
- AVG Volume (30 Days)
- CLSD 230.0K
- DMA 34.6K
- Earning Date
- CLSD 11-12-2024
- DMA 01-01-0001
- Dividend Yield
- CLSD N/A
- DMA 2.04%
- EPS Growth
- CLSD N/A
- DMA N/A
- EPS
- CLSD N/A
- DMA N/A
- Revenue
- CLSD $7,703,000.00
- DMA N/A
- Revenue This Year
- CLSD N/A
- DMA N/A
- Revenue Next Year
- CLSD $91.87
- DMA N/A
- P/E Ratio
- CLSD N/A
- DMA N/A
- Revenue Growth
- CLSD 248.39
- DMA N/A
- 52 Week Low
- CLSD $0.92
- DMA $4.78
- 52 Week High
- CLSD $2.12
- DMA $8.00
- Technical
- Relative Strength Index (RSI)
- CLSD 42.14
- DMA 42.72
- Support Level
- CLSD $0.99
- DMA $8.76
- Resistance Level
- CLSD $1.05
- DMA $8.97
- Average True Range (ATR)
- CLSD 0.05
- DMA 0.11
- MACD
- CLSD 0.00
- DMA -0.03
- Stochastic Oscillator
- CLSD 15.38
- DMA 17.50
About CLSD Clearside Biomedical Inc.
Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.
About DMA Destra Multi-Alternative Fund
Destra Multi-Alternative Fund is a non-diversified, closed-end management investment company that operates as an interval fund with a continuous offering of fund shares. The investment objective of the fund is to seek returns from capital appreciation and income with an emphasis on income generation.